BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21185936)

  • 1. Workshop/conference report on EMA draft guideline on validation of bioanalytical methods.
    Blume H; Brendel E; Brudny-Klöppel M; Grebe S; Lausecker B; Rohde G; Siethoff C
    Eur J Pharm Sci; 2011 Feb; 42(3):300-5. PubMed ID: 21185936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation.
    van Amsterdam P; Companjen A; Brudny-Kloeppel M; Golob M; Luedtke S; Timmerman P
    Bioanalysis; 2013 Mar; 5(6):645-59. PubMed ID: 23484783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period.
    Timmerman P; Goodman J; Golob M; Haslberger T; Knutsson M; Nelson R; Verhaeghe T; White S
    Bioanalysis; 2020 Mar; 12(6s):1-11. PubMed ID: 32323555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.
    Kadian N; Raju KS; Rashid M; Malik MY; Taneja I; Wahajuddin M
    J Pharm Biomed Anal; 2016 Jul; 126():83-97. PubMed ID: 27179186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods.
    Lin ZJ; Li W; Weng N
    Bioanalysis; 2011 Jan; 3(1):57-66. PubMed ID: 21175367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
    Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
    Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing scientific, technical and regulatory innovation in regulated bioanalysis: a discussion paper from the European Bioanalysis Forum.
    Timmerman P; Henderson N; Smeraglia J; Mulder H; Ingelse B; Brudny-Kloeppel M; Companjen A
    Bioanalysis; 2013 Jan; 5(2):139-45. PubMed ID: 23330557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
    Timmerman P; Luedtke S; van Amsterdam P; Brudny-Kloeppel M; Lausecker B; Fischmann S; Globig S; Sennbro CJ; Jansat JM; Mulder H; Thomas E; Knutsson M; Kasel D; White SA; Kall MA; Mokrzycki-Issartel N; Freisleben A; Romero F; Andersen MP; Knebel N; de Zwart M; Laakso S; Hucker RS; Schmidt D; Gordon B; Abbott R; Boulanger P
    Bioanalysis; 2009 Sep; 1(6):1049-56. PubMed ID: 21083073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
    Cocchetto DM
    Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum.
    Timmerman P; Anders Kall M; Gordon B; Laakso S; Freisleben A; Hucker R
    Bioanalysis; 2010 Jul; 2(7):1185-94. PubMed ID: 21083233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance.
    Smith G
    Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222
    [No Abstract]   [Full Text] [Related]  

  • 13. Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline.
    Timmerman P; Barfield M; Cowan K; Ferrari L; Golob M; Goodman J; Kall M; Laurén A; Love I; McDougall S; Nelson R; Pynaert G; Staack RF; Verhaeghe T; White S
    Bioanalysis; 2022 Nov; 14(22):1407-1411. PubMed ID: 36705021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.
    Lowes S; Jersey J; Shoup R; Garofolo F; Needham S; Couerbe P; Lansing T; Bhatti M; Sheldon C; Hayes R; Islam R; Lin Z; Garofolo W; Moussallie M; Teixeira Lde S; Rocha T; Jardieu P; Truog J; Lin J; Lundberg R; Breau A; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Jenkins R; Nicholson R; Lin MH; Karnik S; DeMaio W; Smith K; Cojocaru L; Allen M; Fatmi S; Sayyarpour F; Malone M; Fang X
    Bioanalysis; 2012 Apr; 4(7):763-8. PubMed ID: 22512795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open forum conference on the ICH M13A bioequivalence guideline.
    Blume H; Wedemeyer S; Seidlitz A; Beuerle G; Klein S; Bilensoy E
    Eur J Pharm Sci; 2024 May; 196():106741. PubMed ID: 38452875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conference Report: 4th Japan Bioanalysis Forum Symposium: Japanese guidelines on bioanalytical method validation and latest discussion within the Japanese bioanalyst community.
    Nakayama A; Nakamura T
    Bioanalysis; 2014 Apr; 6(7):915-7. PubMed ID: 24806901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (
    Booth B; Stevenson L; Pillutla R; Buonarati M; Beaver C; Fraier D; Garofolo F; Haidar S; Islam R; James C; Kadavil J; Kavetska O; Li F; Satterwhite C; Savoie N; Subramaniam S; Tampal N; Thway T; Woolf E; Blaye OL; Andisik M; Briscoe C; Cape S; Dasgupta A; Fischer S; Haidar S; Hayes R; Kamerud J; Lima Santos GM; Nehls C; Soo C; Vinter S; Whale E; Xu K; Cho SJ; Edmison A; Kassim S; Rocha TC; Welink J; Amur S; Bandukwala A; Cherry E; Hopper S; Ishii-Watabe A; Kirshner S; Maher K; Pedras-Vasconcelos J; Saito Y; Saunders TS; Skibeli V; Verthelyi D; Wang YM; Yan H
    Bioanalysis; 2019 Dec; 11(23):2099-2132. PubMed ID: 31833782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissues.
    Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lenthéric I; McIntosh M; Dzygiel P; Timmerman P
    Bioanalysis; 2014; 6(12):1617-26. PubMed ID: 25077623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.